February 2011
Dear sir/madam,
On World Tuberculosis Day, TuBerculosis Vaccine Initiative, in collaboration with Calouste Gulbenkian Foun-
dation, Fondation Mérieux, Friends of the Global Fund Europe and Stop TB Partnership, will organize the
following meetings:
The world faces tremendous challenges to combat big health problems, such as Aids, Tuberculosis and
Malaria. Millions of euros have already been spent to develop new tools to combat these diseases, which are
also a threat for Europe. But state budgets of developed countries are under huge pressure. In the meantime,
the importance of innovation on the agendas of European countries and the European Union is rising (EU 2020
DJHQGD(XURSH)ODJVKLS,QLWLDWLYH,QQRYDWLRQ8QLRQ+RZWRKDQGOHWKLVREYLRXVFRQÀLFWRILQWHUHVWV"
On World Tuberculosis Day (24 March) a round table discussion will be organized followed by a symposium
where the possibilities to bring all challenges together will be discussed. An innovative funding model will be
SUHVHQWHGWRDVVXUHWKHGHYHORSPHQWRIQHZWRROVWRFRPEDWGLVHDVHVDQGWRDVVXUH(XURSH¶VOHDGLQJUROHLQ
the development of these tools. >>
Programme:
15h00-15h05: Welcome by Dr. Emílio Rui Vilar, President of the Calouste Gulbenkian Foundation
15h05-16h30: 5RXQGWDEOH7KH¿JKWDJDLQVWWXEHUFXORVLVZKDW¶VQHZLQUHVHDUFK
6SHDNHUV'U-RUJH6DPSDLR816HFUHWDU\*HQHUDO¶V6SHFLDO(QYR\WRVWRS7%
'U3DWULFH'HEUp$PEDVVDGRUIRUWKH¿JKWDJDLQVW$,'6DQGFRPPXQLFDEOHGLVHDVHV
Ministry of foreign and European affairs, France
'U&KULVWLDQ/LHQKDUGW6HQLRUVFLHQWL¿FDGYLVRU6WRS7%3DUWQHUVKLS
16h45-18h00: 6\PSRVLXP,QQRYDWLYHIXQGLQJDQGWUDQVODWLRQRIGLVFRYHULHVLQWRDGGHGYDOXH
QHZYDFFLQHVIRU7%
K ,QWURGXFWLRQE\'U-RUJH6DPSDLR816HFUHWDU\*HQHUDO¶V6SHFLDO(QYR\WRVWRS7%
16h50: Ms. Michèle Barzach, France, former Minister of health and President of ‘Friends of the
Global Fund Europe: The needs of the world for innovative ways to combat Aids, Tuberculosis
and Malaria.
K 0U%HQRvW0LULEHO'LUHFWRU*HQHUDO)RQGDWLRQ0pULHX[)UDQFH¶:KLFKLQQRYDWLYHPHDVXUHV
DUHQHHGHGWRDFWPRUHTXLFNO\DJDLQVWWXEHUFXORVLVLQWKH¿HOG"¶
17h10: Dr. Onno Ruding, chairman of the Board of the Centre for European Policy Studies in
%UXVVHOVIRUPHUPLQLVWHURI¿QDQFHVRI7KH1HWKHUODQGVµ7%9,DVDPRGHO¶
17h20: Dr. Joris Vandeputte, TBVI: ‘Translating science into products through innovative funding;;
GHYHORSLQJWXEHUFXORVLVYDFFLQHV¶
17h30: Ms. Clara de la Torre, Director of Research and Innovation within the Directorate General of
Research, representing European commissioner for research, innovation and Science
*HRJKHJDQ4XLQQµ7KH,FRQRP\¶
K 0V)UDQoRLVH*URVVHWrWH0(3WREHFRQ¿UPHGµ7KHUROHRIWKH(XURSHDQ3DUOLDPHQWLQ
VWUHQJWKHQLQJDQLQQRYDWLYH(XURSH¶
K 'LVFXVVLRQPRGHUDWHGE\'U3DWULFH'HEUp$PEDVVDGRUIRUWKH¿JKWDJDLQVW$,'6DQG
communicable diseases, Ministry of foreign and European affairs, France
18h00: Cocktail reception.
:HZRXOGEHYHU\KRQRXUHGLI\RXZRXOGOLNHWRMRLQWKLVURXQGWDEOHDQGV\PSRVLXP3OHDVH¿OOLQWKH
registration form on www.tbvi.eu/registration_formEHIRUH0DUFKWRFRQ¿UP
Kind regards,
Ms. Isabel Mota, Trustee of the Gulbenkian Foundation in Lisbon, Portugal
Mr. Benoît Miribel, Director General Fondation Mérieux, Lyon, France
Mrs Michèle Barzach, Former Minister of Health, President of Friends of the Global Fund Europe, Paris, France
Dr Lucica Ditiu, Executive Secretary, Stop TB Partnership, Switzerland
Dr. Jelle Thole, Director TuBerculosis Vaccine Initiative (TBVI), The Netherlands